Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

iThriveMD of Eastlake — Peptide Therapy in Chula Vista, CA

iThriveMD of Eastlake Nearby Clinics Chula Vista, CA Peptides & Treatments About iThriveMD of Eastlake operates a LegitScript-certified wellness clinic in Chula Vista, California, where a multidisciplinary team of medical doctors and naturopathic doctors deliv

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

iThriveMD of Eastlake

Nearby Clinics

Chula Vista, CA

Peptides & Treatments

About

iThriveMD of Eastlake operates a LegitScript-certified wellness clinic in Chula Vista, California, where a multidisciplinary team of medical doctors and naturopathic doctors deliver peptide-based therapies and precision longevity protocols. The clinic's approach integrates comprehensive biomarker testing with targeted interventions designed to address metabolic dysfunction, hormonal decline, and age-related cellular deterioration. Patients receive in-person consultations at the Eastlake location, where providers assess individual health markers and design treatment plans that may include peptide therapy, intravenous nutrient delivery, and ongoing monitoring to track physiological changes over time.

iThriveMD of Eastlake offers an extensive peptide therapy program with 5 different peptides available, including metabolic peptides including Semaglutide, Tirzepatide, growth hormone secretagogues like Sermorelin, and other specialized compounds. Treatment selection is individualized based on comprehensive health assessments and patient goals.

The medical team at iThriveMD of Eastlake includes both MDs and NDs who collaborate on patient care, combining conventional medical training with naturopathic principles. This dual-credentialed approach allows the clinic to address cardiovascular risk factors, neurocognitive decline, musculoskeletal deterioration, and cancer prevention strategies within a single care framework. Providers review lipid panels, inflammatory markers, hormone levels, and metabolic indicators to identify intervention points, then prescribe therapies that target those specific imbalances. The clinic's emphasis on preventive healthcare means patients often begin treatment before symptomatic disease develops, using biomarker trends to guide early intervention.

Patients visiting the Chula Vista clinic undergo initial consultations that include detailed health histories, physical examinations, and laboratory work to establish baseline measurements. Follow-up visits track changes in body composition, energy levels, cognitive function, and other patient-reported outcomes alongside objective biomarker data. The clinic provides IV therapy administration on-site, allowing patients to receive NAD+ infusions and other intravenous treatments during scheduled appointments. Treatment plans are adjusted based on ongoing lab results and patient response, with providers modifying peptide dosages, infusion frequencies, or adjunctive therapies as indicated by clinical progress.

What distinguishes iThriveMD of Eastlake from standard primary care is the clinic's focus on optimizing physiological function rather than merely treating diagnosed conditions. The integration of hormone optimization, brain health protocols, and metabolic interventions under one roof allows patients to address multiple aspects of aging and wellness simultaneously. The clinic's LegitScript certification provides verification of compliance with telemedicine and pharmacy standards, while the in-person consultation model ensures direct provider oversight of all treatments. For Chula Vista residents seeking data-driven longevity medicine with access to both conventional and naturopathic medical expertise, iThriveMD offers a comprehensive platform for proactive health management.

Care Team

iThriveMD· Multiple MDs and NDs on staff

Our Team

Dr. Samir Damani, MD

Founder & Cardiovascular Specialist

Dr. Thomas Macsay, ND

Naturopathic Doctor & VP of Clinical Operations

Dr. John Christianson, ND

Naturopathic Doctor

Dr. Joseph Shum, ND

Patient Reviews

Pricing

Consultation: Free

Services Offered

Microdosing Tirzepatide

6-Month Program

3-Month Program

Tirzepatide

Tirzepatide injections

Semaglutide

Semaglutide injections

Glutathione injections

Detox

Nutrient Injections

Nutrients

PT-141

Sexual health

Methylene Blue

Cognitive function

Metformin

Metabolic

Sermorelin

Muscle & energy

IV Therapy

Custom IV therapy

NAD+ Wafers

Energy & mood

TRT with Enclomiphene

TRT therapy

FBHRT

Female hormones

LDN

Reduce inflammation

+5 more services — contact clinic for full list

FAQ

MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What if I travel frequently? Can I continue peptide therapy?

Most injectable peptides travel reasonably well with proper handling. Your clinic should provide guidance on traveling with peptides, including storage requirements and TSA considerations. Understanding peptide stability at room temperature helps plan for travel situations.

Source: seekpeptides.com ↗
comparison

Inflammation reduction versus fat reduction: which matters more?

This is the question that the Italian exenatide study highlighted so powerfully. Case 1 lost no weight but still experienced pain reduction and measurable changes in subcutaneous fat thickn…

Source: seekpeptides.com
comparison

Keto supplements versus GLP-1 medications: they are not the same thing

This distinction requires absolute clarity because confusion here can be dangerous. Exogenous ketone supplements, MCT oil products, and "keto pills" sold over the counter are NOT GLP-1 rece…

Source: seekpeptides.com
Research context

Read sources and limitations before applying a claim.

What the Research Says

While peptide therapy is still an emerging field, several high-quality studies support its potential: BPC-157: Animal studies and early human trials show accelerated healing of tendons, ligaments, and gut lining. Thymosin Alpha-1 (Tα1): Shown to enhance immune response in viral infections and improve vaccine efficacy. CJC-1295 & Ipamorelin: Commonly used for growth hormone stimulation, these peptides have been linked to increased lean muscle mass, reduced body fat, and improved sleep quality. PT-141 (Bremelanotide): FDA-approved for female sexual dysfunction, illustrating that peptides can pass rigorous regulatory hurdles. It's important to note that while some peptides have robust clinical data and regulatory approval, others are still under investigation. Always consult a qualified healthcare provider before starting any new therapy.

Source: ubiehealth.com ↗

Evidence-Based, Clinically Guided Care

Sourced from FDA-approved USA manufacturers Our peptide protocols utilize advanced, clinically validated peptides such as CJC-1295, BPC-157, and PT-141. Each treatment plan is grounded in rigorous clinical data and tailored for safe, effective results—helping you optimize your body’s natural repair, recovery, and performance pathways.

Source: extension.health ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Side effects

Gastrointestinal side effects compound the problem

Nausea affects 44% of semaglutide users and 28% of tirzepatide users in clinical trials. Vomiting hits 24% and 13% respectively. Diarrhea affects 30% and 23%. These are not minor inconveniences. Each episode of vomiting or diarrhea strips nutrients from your body before they can be absorbed. When you are already eating less, losing nutrients through GI side effects creates a double hit. Your intake is down and your losses are up. This is why the first few months of GLP-1 therapy, when side effects are most common and dose titration is happening, represent the highest risk period for developing deficiencies. Constipation, which affects roughly one in four users, presents its own challenges. While it does not directly cause nutrient loss, it often leads people to reduce fiber intake further, which compounds the problem of inadequate nutrition.

Source: seekpeptides.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →